Oncology Today with Dr Neil Love
Oncology Today with Dr Neil Love
✓

Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

· Vis noter
01:57:32
Podcasts
RSS
Link

OM DENNE EPISODE

Featuring perspectives from Dr Melissa Alsina, Dr Hans Lee, Dr Sagar Lonial and Dr Paul G Richardson, moderated by Dr Lonial, including the following topics:

  • Introduction (0:00)
  • Integrating Bispecific Antibodies into the Management of Relapsed/Refractory (R/R) Multiple Myeloma (MM) — Dr Lee (1:45)
  • Current Utility of Antibody-Drug Conjugates for MM — Dr Lonial (33:55)
  • Potential Role of Cereblon E3 Ligase Modulators in Therapy for MM — Dr Richardson (59:42)
  • Chimeric Antigen Receptor T-Cell Therapy for R/R MM — Dr Alsina (1:30:24)

CME information and select publications

Medicin
Uddannelse
Sundhed & fitness
Medicin
Videnskab
Engelsk
USA
BrugAPItil at hente denne episode iJSON

I DENNE EPISODE

Redigér disse tags

VIS NOTER 🔗

00:00:00Introduction
00:01:45Integrating Bispecific Antibodies into the Management of Relapsed/Refractory (R/R) Multiple Myeloma (MM) — Dr Lee
00:33:55Current Utility of Antibody-Drug Conjugates for MM — Dr Lonial
00:59:42Potential Role of Cereblon E3 Ligase Modulators in Therapy for MM — Dr Richardson
01:30:24Chimeric Antigen Receptor T-Cell Therapy for R/R MM — Dr Alsina

UDSKRIFT 🔗

Are you the producer of this podcast? Add a podcast transcript
Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

SØG BLANDT TIDLIGERE EPISODER

Søg efter gamle afsnit af Oncology Today with Dr Neil Love.
Integrer denne søgefelt på dit websted

ANDRE EPISODE I DENNE PODCAST

Prostate Cancer with PTEN Deficiency — An Interview with Dr Neeraj Agarwal

Prostate Cancer with PTEN Deficiency — An Interview with Dr Neeraj Agarwal

Featuring an interview with Dr Neeraj Agarwal, including the following topics: Impact of PTEN deficiency on PI3K/AKT/mTOR pathway; optimal approaches to testing (0:00) Approaches to monitoring for disease progression in patients who are PTEN deficient; prognostic significance and implications for …
00:52:24
DEL
GEM
Diffuse Large B-Cell Lymphoma — Proceedings from a Symposium Held in Conjunction with the American Oncology Network

Diffuse Large B-Cell Lymphoma — Proceedings from a Symposium Held in Conjunction with the American Oncology Network

Featuring perspectives from Dr Ann LaCasce and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics: Introduction (0:00) First-Line Treatment (1:33) Bispecific Antibodies and Chimeric Antigen Receptor T-Cell Therapy (20:36) CME information and select publications
00:50:22
DEL
GEM
Lung Cancer — Proceedings from a Symposium Held in Conjunction with the American Oncology Network

Lung Cancer — Proceedings from a Symposium Held in Conjunction with the American Oncology Network

Featuring perspectives from Dr Stephen V Liu and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics: Introduction (0:00) EGFR Mutations (2:23) HER2 Alterations (22:40) Available and Investigational Immunotherapies (32:14) Small Cell Lung Cancer (40:48) CME information…
00:50:33
DEL
GEM
Diffuse Large B-Cell Lymphoma — An Interview with Dr L Elizabeth Budde on Employing CD20 x CD3 Bispecific Antibodies

Diffuse Large B-Cell Lymphoma — An Interview with Dr L Elizabeth Budde on Employing CD20 x CD3 Bispecific Antibodies

Featuring an interview with Dr L Elizabeth Budde, including the following topics: Considerations for selecting between bispecific antibodies (BsAbs); monotherapy versus combination therapy (0:00) Management of BsAb-induced cytokine release syndrome and other toxicities (7:35) Use of BsAbs in the f…
00:47:06
DEL
GEM
HER2-Positive Gynecologic Cancers — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer

HER2-Positive Gynecologic Cancers — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer

Featuring perspectives from Dr Joyce F Liu, Dr David M O'Malley and Dr Brian M Slomovitz, moderated by Dr O'Malley, including the following topics: Case: A woman in her mid 60s with metastatic serous endometrial carcinoma that is HER2 IHC 3+ who received first-line carboplatin/paclitaxel/trastuzum…
00:23:25
DEL
GEM
Ansvarsfraskrivelse: Podcasten og kunstværket, der er indlejret på denne side, er fra Dr. Neil Love, som tilhører dens ejer og ikke er tilknyttet eller godkendt af Listen Notes, Inc.
PROMOTED
We’re selling some of our podcast-related domain names, including breaker.fm, Podcast.mov, and Listen.Host. Place your bid on eBay.
We’re selling some of our podcast-related domain names, including breaker.fm, Podcast.mov, and Listen.Host. Place your bid on eBay.
Bid on eBay

ANBEFALINGER
Brug API til at hente denne episode